Patents Assigned to Hunter Immunology Ltd.
  • Patent number: 8425917
    Abstract: The present invention describes the use of a mutant form of EtxB or CtxB to deliver an agent to a target cell wherein the mutant has GM-1 binding activity; but wherein the mutant has a reduced immunogenic and immunomodulatory activity relative to the wild type form of EtxB or CtxB.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: April 23, 2013
    Assignee: Hunter Immunology Ltd
    Inventor: Timothy Raymond Hirst
  • Patent number: 7422752
    Abstract: The present invention describes the use of a mutant form of EtxB or CtxB to deliver an agent to a target cell wherein the mutant has GM-1 binding activity; but wherein the mutant has a reduced immunogenic and immunomodulatory activity relative to the wild type form of EtxB or CtxB.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: September 9, 2008
    Assignee: Hunter Immunology Ltd.
    Inventor: Timothy Raymond Hirst